Fig. 7

Correlation of candidate circRNAs including Circ-PTK2 (a), circ-ATIC (b), circ-RNF217 (c), circ-RERE (d), circ-SETD5 (e), circ-NAGPA (f), circ-KCNQ5 (g), circ-CSPP1 (h), circ-SFMPT2 (i), circ-UGGT2 (j), circ-AFF2 (k), circ-WWC3 (l), circ-SLAIN1 (m), circ-WDR37-1 (n), circ-WDR37-2 (o), circ-DNAJC5 (p), circ-KLHL2 (q), circ-IQGAP1 (r), circ-AL137655 (s) and circ-ASPA1 (t) with PFS in MM patients. PFS was displayed with Kaplan-Meier curves, and the difference in survival was determined by the log-rank test. P < 0.05 was considered significant. PFS, progression free survival; MM, multiple myeloma; circRNAs, circular RNAs